|
LEC
| | |
|
Oxidative Phosphorylation
|
4.52E-17
|
29
|
|
Ubiquinone biosynthesis
|
8.04E-12
|
14
|
|
Purine metabolism
|
0.00166
|
18
|
|
Pyrimidine metabolism
|
0.0274
|
9
|
|
Limbus
| | |
|
Pentose Phosphate Pathway
|
0.0014
|
5
|
|
Oxidative Phosphorylation
|
0.00795
|
7
|
|
Valine, Leucine and Isoleucine Biosynthesis
|
0.00851
|
2
|
|
Alanine and aspartate metabolism
|
0.0151
|
3
|
|
Glycolysis/gluconeogenesis
|
0.047
|
4
|
|
Cornea
| | |
|
Oxidative Phosphorylation
|
3.48E-21
|
41
|
|
Ubiquinone Biosynthesis
|
2.14E-08
|
16
|
|
Purine metabolism
|
0.000118
|
30
|
|
Alanine and Aspartate metabolism
|
0.000869
|
9
|
|
Glutathione metabolism
|
0.00607
|
8
|
|
Glycolysis/gluconeogenesis
|
0.00855
|
12
|
|
Lysine biosynthesis
|
0.0402
|
2
|
|
Citrate cycle
|
0.042
|
4
|
|
Pyruvate metabolism
|
0.0451
|
8
|
|
Canonical Signaling Pathways
| | |
|
LEC
| | |
|
NRF2-mediated Oxidative Stress Response
|
2.29E-05
|
16
|
|
Nucleotide Excision Repair Pathway
|
3.17E-05
|
7
|
|
Protein Ubiquitination Pathway
|
2.06E-05
|
16
|
|
Estrogen Receptor Signaling
|
8.79E-03
|
8
|
|
Glucocorticoid Receptor Signaling
|
1.81E-02
|
13
|
|
Limbus
| | |
|
NRF2-mediated Oxidative Stress Response
|
2.81E-02
|
7
|
|
Regulation of actin based motility by Rho
|
4.51E-02
|
4
|
|
Cornea
| | |
|
NRF2 mediated Oxidative Stress Response
|
2.51E-04
|
21
|
|
Protein Ubiquitination Pathway
|
3.09E-07
|
26
|
|
Estrogen Receptor Signaling
|
3.67E-04
|
15
|
|
Antigen Presentation Pathway
|
1.29E-03
|
7
|
|
VDR/RXR Activation
|
6.31E-03
|
10
|
|
Glucocorticoid Receptor Signaling
|
3.05E-02
|
20
|
|
Nucleotide Excision repair
|
2.77E-04
|
8
|
